Quaker BioVentures II LP 13D and 13G filings for TELA Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-23 06:31 am Sale | 2022-06-02 | 13G | TELA Bio, Inc. TELA | Quaker BioVentures II LP | 18,096 0.120% | -1,751,100 (-98.98%) | Filing |
| 2022-02-14 4:05 pm Unchanged | 2021-12-31 | 13G | TELA Bio, Inc. TELA | Quaker BioVentures II LP | 1,769,196 12.200% | 0 (Unchanged) | Filing |
| 2021-01-26 2:25 pm Unchanged | 2020-12-31 | 13G | TELA Bio, Inc. TELA | Quaker BioVentures II LP | 1,769,196 12.200% | 0 (Unchanged) | Filing |
| 2020-02-14 4:26 pm Purchase | 2019-12-31 | 13G | TELA Bio, Inc. TELA | Quaker BioVentures II LP | 1,769,196 15.500% | 1,769,196 (New Position) | Filing |